130 related articles for article (PubMed ID: 3098915)
1. Fulminant hepatitis in asymptomatic hepatitis B surface antigen carriers in Greece.
Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayannis A; Smedile A; Engle R; Ticehurst JR; Feinstone SM; Purcell RH
J Med Virol; 1986 Dec; 20(4):371-9. PubMed ID: 3098915
[TBL] [Abstract][Full Text] [Related]
2. 19S and 7-8S forms of IgM antibody to hepatitis B core antigen in acute icteric hepatitis superimposed on hepatitis B surface antigen carriage.
Tassopoulos NC; Sjogren MH; Purcell RH
Infection; 1990; 18(6):376-80. PubMed ID: 2127587
[TBL] [Abstract][Full Text] [Related]
3. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
4. Etiology of fulminant viral hepatitis in Greece.
Papaevangelou G; Tassopoulos N; Roumeliotou-Karayannis A; Richardson C
Hepatology; 1984; 4(3):369-72. PubMed ID: 6327484
[TBL] [Abstract][Full Text] [Related]
5. Chronic evolution of acute hepatitis B: the significance of simultaneous infections with hepatitis C and D. Copenhagen Hepatitis Acuta Programme.
Krogsgaard K; Wantzin P; Mathiesen L; Ring-Larsen H
Scand J Gastroenterol; 1991 Mar; 26(3):275-80. PubMed ID: 1906632
[TBL] [Abstract][Full Text] [Related]
6. Significance of IgM antibody to hepatitis B core antigen in a Greek population with chronic hepatitis B virus infection.
Tassopoulos NC; Sjogren MH; Ticehurst JR; Engle RE; Roumeliotou-Karayannis A; Gerin JL; Purcell RH; Papaevangelou G
Liver; 1986 Oct; 6(5):275-80. PubMed ID: 3784781
[TBL] [Abstract][Full Text] [Related]
7. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults.
Tassopoulos NC; Papaevangelou GJ; Sjogren MH; Roumeliotou-Karayannis A; Gerin JL; Purcell RH
Gastroenterology; 1987 Jun; 92(6):1844-50. PubMed ID: 3569758
[TBL] [Abstract][Full Text] [Related]
8. Delta infection and hepatitis B virus replication in Danish patients with fulminant hepatitis B.
Krogsgaard K; Mathiesen LR; Aldershvile J; Kryger P; Andersson P; Hansson BG; Nielsen JO; Ranek L
Scand J Infect Dis; 1988; 20(2):127-33. PubMed ID: 3135586
[TBL] [Abstract][Full Text] [Related]
9. Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey.
Saracco G; Macagno S; Rosina F; Rizzetto M
Ann Intern Med; 1988 Mar; 108(3):380-3. PubMed ID: 3341675
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of anti-HBc IgM in high HBV prevalence areas.
Papaevangelou G; Roumeliotou-Karayannis A; Tassopoulos N; Stathopoulou P
J Med Virol; 1984; 13(4):393-9. PubMed ID: 6429276
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte hepatitis B surface antigen. Diagnostic evaluation of patients with clinically acute hepatitis B surface antigen-positive hepatitis.
Su IJ; Kuo TT; Liaw YF
Arch Pathol Lab Med; 1985 May; 109(5):400-2. PubMed ID: 3885902
[TBL] [Abstract][Full Text] [Related]
12. A possible misdiagnosis in patients presenting with acute HBsAg-negative hepatitis: the role of hepatitis delta virus.
Caredda F; Antinori S; Pastecchia C; Coppin P; Arici C; Fracassetti O
Infection; 1988; 16(6):358-9. PubMed ID: 3220581
[TBL] [Abstract][Full Text] [Related]
13. [Role of delta infection in fulminant course of viral hepatitis].
Khlopova IN; Ketiladze ES; Farber NA
Klin Med (Mosk); 1990 Nov; 68(11):46-9. PubMed ID: 2283813
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic significance of IgM antibody to hepatitis delta virus in fulminant hepatitis B.
Tassopoulos NC; Koutelou MG; Macagno S; Zorbas P; Rizzetto M
J Med Virol; 1990 Mar; 30(3):174-7. PubMed ID: 2341833
[TBL] [Abstract][Full Text] [Related]
15. Clinical and serological outcome of acute delta infection.
Buti M; Estebán R; Jardi R; Allende H; Estebán JI; Genesca J; Guardia J
J Hepatol; 1987 Aug; 5(1):59-64. PubMed ID: 3655311
[TBL] [Abstract][Full Text] [Related]
16. Serological markers of hepatitis B virus and hepatitis D virus infections in Greek adults with primary hepatocellular carcinoma.
Tassopoulos NC; Theodoropoulos G; Sjogren MH; Engle R; Purcell RH
Infection; 1989; 17(1):17-9. PubMed ID: 2537800
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of HBV, HDV and HIV infections among intravenous drug addicts in Greece.
Roumeliotou-Karayannis A; Tassopoulos N; Karpodini E; Trichopoulou E; Kotsianopoulou M; Papaevangelou G
Eur J Epidemiol; 1987 Jun; 3(2):143-6. PubMed ID: 3475213
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis D virus (delta agent) superinfection in an endemic area of hepatitis B infection: immunopathologic and serologic findings.
Lee SD; Wang JY; Wu JC; Tsai YT; Lo KJ; Lai KH; Tsay SH; Govindarajan S
Scand J Infect Dis; 1987; 19(2):173-7. PubMed ID: 3616486
[TBL] [Abstract][Full Text] [Related]
19. Is anti-HBc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?
Lai MC; Tong MJ; Nowicki MJ; Lee SD
Hepatology; 1988; 8(3):514-7. PubMed ID: 2453429
[TBL] [Abstract][Full Text] [Related]
20. Incidence of hepatitis delta virus infection in acute HBsAg-negative hepatitis.
Caredda F; Antinori S; Pastecchia C; Coppin P; Palla M; Ponzetto A; Rizzetto M; Moroni M
J Infect Dis; 1989 May; 159(5):977-9. PubMed ID: 2496175
[No Abstract] [Full Text] [Related]
[Next] [New Search]
